Active Ingredient History
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Anemia (Phase 2)
Anemia, Sickle Cell (Phase 2)
Anthracyclines (Phase 2)
Breast Neoplasms (Phase 2)
Carcinoma, Non-Small-Cell Lung (Phase 1)
Carcinoma, Transitional Cell (Phase 1)
Cerebral Arterial Diseases (Early Phase 1)
Diabetes Mellitus, Type 2 (Phase 4)
DNA Repair-Deficiency Disorders (Phase 1)
Endothelium-Dependent Relaxing Factors (Phase 2)
Endotoxemia (Phase 1)
Fatigue Syndrome, Chronic (Phase 1)
Healthy Volunteers (Phase 4)
Heart Failure (Phase 1)
HIV (Phase 1)
Hodgkin Disease (Phase 1)
Hypercapnia (Phase 1)
Hyperlipidemias (Phase 2/Phase 3)
Hypertension (Phase 1)
Hypertension, Pulmonary (Phase 1)
Hypotension, Orthostatic (Phase 2)
Hypoxia (Phase 1)
Intestinal Neoplasms (Phase 1)
Melanoma (Phase 1)
Metabolic Syndrome (Phase 1)
Nitric Oxide (Phase 2)
Obesity (Phase 4)
Orthostatic Intolerance (Phase 1)
Pulmonary Disease, Chronic Obstructive (Phase 1)
Saliva (Phase 1)
Sarcopenia (Phase 1)
Sleep Apnea, Obstructive (Phase 4)
Spinal Cord Injuries (Phase 2)
Squamous Cell Carcinoma of Head and Neck (Phase 1)
Syncope, Vasovagal (Early Phase 1)
Triple Negative Breast Neoplasms (Phase 2)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue